{"id":34223,"date":"2026-02-10T05:59:01","date_gmt":"2026-02-10T05:59:01","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/anticoagulants-market-mordor\/"},"modified":"2026-09-11T22:01:22","modified_gmt":"2026-09-11T13:01:22","slug":"anticoagulants-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/anticoagulants-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \ud56d\uc751\uace0\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026 &#8211; 2031)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/anticoagulants-market-1767095939142-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/anticoagulants-market-size-image-1767883914380.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud604\ud669<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc2ec\ud608\uad00 \uc9c8\ud658 \ubc0f \uc2ec\ubc29\uc138\ub3d9 \uc720\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc640\ud30c\ub9b0 \ub300\ube44 NOACs\uc758 \ube60\ub978 \ucc44\ud0dd<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc99d\uac00\ud558\ub294 \ub178\uc778 \uc778\uad6c<\/li>\n<li class=\"toc-level-3\">4.2.4 VTE \uc608\ubc29\uc744 \uc704\ud55c \uc720\ub9ac\ud55c \uc784\uc0c1 \uc9c0\uce68<\/li>\n<li class=\"toc-level-3\">4.2.5 AI \uae30\ubc18 \ub9de\ucda4\ud615 \ud56d\uc751\uace0\uc81c \uc6a9\ub7c9 \uc870\uc808 \ub3c4\uad6c<\/li>\n<li class=\"toc-level-3\">4.2.6 \ucf54\ub85c\ub09819 \uc774\ud6c4 \uc678\ub798 \ud608\uc804 \uc608\ubc29 \uc5f0\uc7a5<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc8fc\uc694 NOACs\uc758 \ud2b9\ud5c8 \ub9cc\ub8cc \ubc0f \uc81c\ub124\ub9ad \uce68\uc2dd<\/li>\n<li class=\"toc-level-3\">4.3.2 \ucd9c\ud608 \uc704\ud5d8 \uc6b0\ub824\ub85c \uc778\ud55c \ucc44\ud0dd \uc81c\ud55c<\/li>\n<li class=\"toc-level-3\">4.3.3 \ub3fc\uc9c0 \ud5e4\ud30c\ub9b0 \uacf5\uae09\ub9dd \ucde8\uc57d\uc131<\/li>\n<li class=\"toc-level-3\">4.3.4 RNAi \/ \uc720\uc804\uc790 \uce68\ubb35 \uc81c\uc81c\uc5d0 \ub300\ud55c \uaddc\uc81c \ubd88\ud655\uc2e4\uc131<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uac00\uce58 \/ \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1\uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58 &#8211; USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc57d\ubb3c \ubd84\ub958\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc2e0\uaddc \uacbd\uad6c\uc6a9 \ud56d\uc751\uace0\uc81c (NOAC)<\/li>\n<li class=\"toc-level-3\">5.1.2 \ud5e4\ud30c\ub9b0 &amp; \uc800\ubd84\uc790\ub7c9 \ud5e4\ud30c\ub9b0 (LMWH)<\/li>\n<li class=\"toc-level-3\">5.1.3 \ube44\ud0c0\ubbfc K \uae38\ud56d\uc81c<\/li>\n<li class=\"toc-level-3\">5.1.4 Factor XIa \uc5b5\uc81c\uc81c<\/li>\n<li class=\"toc-level-3\">5.1.5 \ube44\uacbd\uad6c \uc9c1\uc811 \ud2b8\ub86c\ube48 \uc5b5\uc81c\uc81c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \ud22c\uc5ec \uacbd\ub85c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uacbd\uad6c\uc6a9 \ud56d\uc751\uace0\uc81c<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc8fc\uc0ac\uc81c \ud56d\uc751\uace0\uc81c<\/li>\n<li class=\"toc-level-3\">5.2.3 \uc774\uc2dd\ud615 \/ \uc7a5\uae30 \uc9c0\uc18d\ud615 \uc804\ub2ec \uc2dc\uc2a4\ud15c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc801\uc6a9 \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc2ec\ubc29\uc138\ub3d9 &amp; \uc2ec\uadfc\uacbd\uc0c9<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc2ec\ubd80\uc815\ub9e5 \ud608\uc804\uc99d<\/li>\n<li class=\"toc-level-3\">5.3.3 \ud3d0\uc0c9\uc804\uc99d<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc554 \uad00\ub828 \ud608\uc804\uc99d<\/li>\n<li class=\"toc-level-3\">5.3.5 \uae30\uacc4\uc2dd \uc2ec\uc7a5 \ud310\ub9c9 &amp; \uae30\ud0c0 \uc2ec\uc7a5 \uad00\ub828 \uc6a9\ub3c4<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uc720\ud1b5 \ucc44\ub110\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubcd1\uc6d0 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc18c\ub9e4 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc628\ub77c\uc778 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.4.4 \uc804\ubb38 \ud074\ub9ac\ub2c9<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uae30\ud0c0 \uc911\ub3d9 &amp; \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 ((\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Alexion Pharmaceuticals Inc.<\/li>\n<li class=\"toc-level-3\">6.3.2 Anthos Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.3 Aspen Pharma Holdings Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.4 Astellas Pharma Inc.<\/li>\n<li class=\"toc-level-3\">6.3.5 Bayer AG<\/li>\n<li class=\"toc-level-3\">6.3.6 Boehringer Ingelheim GmbH<\/li>\n<li class=\"toc-level-3\">6.3.7 Bristol-Myers Squibb<\/li>\n<li class=\"toc-level-3\">6.3.8 Daiichi Sankyo Co. Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.9 Dr. Reddy&#8217;s Laboratories Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.10 F. Hoffmann-La Roche AG<\/li>\n<li class=\"toc-level-3\">6.3.11 Ionis Pharmaceuticals Inc.<\/li>\n<li class=\"toc-level-3\">6.3.12 Johnson &amp; Johnson (Janssen)<\/li>\n<li class=\"toc-level-3\">6.3.13 Leo Pharma A\/S<\/li>\n<li class=\"toc-level-3\">6.3.14 Merck &amp; Co. Inc.<\/li>\n<li class=\"toc-level-3\">6.3.15 Mitsubishi Tanabe Pharma<\/li>\n<li class=\"toc-level-3\">6.3.16 Nektar Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.17 Novartis AG<\/li>\n<li class=\"toc-level-3\">6.3.18 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.3.19 Sanofi SA<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ud56d\uc751\uace0\uc81c \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc804\ub9dd (2026-2031)<\/p>\n<p>\ud56d\uc751\uace0\uc81c \uc2dc\uc7a5\uc740 2026\ub144 375\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\ub85c \ucd94\uc815\ub418\uba70, 2031\ub144\uc5d0\ub294 511\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \ub3c4\ub2ec\ud558\uc5ec \uc608\uce21 \uae30\uac04(2026-2031\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 6.36%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \uc2ec\ud608\uad00 \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00, \uc2e0\uaddc \uacbd\uad6c\uc6a9 \ud56d\uc751\uace0\uc81c(NOACs)\uc758 \ube60\ub978 \ucc44\ud0dd, \uadf8\ub9ac\uace0 \uae09\uc131\uae30 \uc774\ud6c4 \ud608\uc804 \uc608\ubc29 \ud504\ub85c\ud1a0\ucf5c\uc758 \ud655\ub300\uc5d0 \uc8fc\ub85c \uae30\uc778\ud569\ub2c8\ub2e4.<\/p>\n<p>1. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \ub3d9\ub825<\/p>\n<p>\ud56d\uc751\uace0\uc81c \uc2dc\uc7a5\uc740 \uc2ec\ud608\uad00 \uc9c8\ud658 \ubc0f \uc2ec\ubc29\uc138\ub3d9\uc758 \ud655\uc0b0, NOACs\uc758 \ube60\ub978 \ub3c4\uc785, \uace0\ub839\ud654 \uc778\uad6c \uc99d\uac00, \uc815\ub9e5\ud608\uc804\uc0c9\uc804\uc99d(VTE) \uc608\ubc29\uc744 \uc704\ud55c \uc784\uc0c1 \uc9c0\uce68\uc758 \uac15\ud654, \uc778\uacf5\uc9c0\ub2a5(AI) \uae30\ubc18 \ub9de\ucda4\ud615 \ud56d\uc751\uace0\uc81c \uc6a9\ub7c9 \uc870\uc808 \ub3c4\uad6c\uc758 \ubc1c\uc804, \uadf8\ub9ac\uace0 \ucf54\ub85c\ub09819 \uc774\ud6c4 \uc678\ub798 \ud608\uc804 \uc608\ubc29\uc758 \ud655\ub300 \ub4f1 \uc5ec\ub7ec \uc694\uc778\uc5d0 \uc758\ud574 \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788, 2024\ub144 \uc720\ub7fd \uc2ec\uc7a5\ud559\ud68c(ESC) \uc9c0\uce68\uc740 \uacbd\uad6c\uc6a9 \ud56d\uc751\uace0\uc81c \ud22c\uc5ec \uae30\uc900\uc744 \ub0ae\ucdb0 \uce58\ub8cc \ub300\uc0c1 \ud658\uc790\uad70\uc744 \uc57d 15% \ud655\ub300\ud588\uc73c\uba70, \ubbf8\uad6d \ub1cc\uc878\uc911 \ub370\uc774\ud130\uc5d0 \ub530\ub974\uba74 \uc2ec\ubc29\uc138\ub3d9 \uad00\ub828 \uc0ac\uac74\uc758 30\uc77c \uc0ac\ub9dd\ub960\uc774 25%\ub97c \ucd08\uacfc\ud558\uc5ec \uc608\ubc29 \uce58\ub8cc\uc758 \uc911\uc694\uc131\uc774 \ubd80\uac01\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>NOACs\ub294 \ubaa8\ub2c8\ud130\ub9c1 \ubd80\ub2f4 \uac10\uc18c\uc640 \uc6b0\uc218\ud55c \uc548\uc804\uc131 \ud504\ub85c\ud30c\uc77c \ub355\ubd84\uc5d0 2025\ub144 \uae30\uc900 \ubbf8\uad6d \ub0b4 \uc2e0\uaddc \ucc98\ubc29\uc758 70% \uc774\uc0c1\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc544\ud53d\uc0ac\ubc18, \ub9ac\ubc14\ub85d\uc0ac\ubc18, \uc5d0\ub3c5\uc0ac\ubc18, \ub2e4\ube44\uac00\ud2b8\ub780\uc758 \uc804 \uc138\uacc4 \ub9e4\ucd9c\uc740 2024\ub144\uc5d0 150\uc5b5 \ub2ec\ub7ec\ub97c \ub118\uc5b4\uc130\uc73c\uba70, \uc640\ud30c\ub9b0 \ub300\ube44 \ub450\uac1c\ub0b4 \ucd9c\ud608\ub960\uc774 \uc57d 50% \ub0ae\uc544 \uc758\ub8cc\uc9c4\uc758 \uc2e0\ub8b0\ub97c \uc5bb\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc640\ud30c\ub9b0\uc740 \ud604\uc7ac \uae30\uacc4\uc2dd \uc2ec\uc7a5 \ud310\ub9c9, \uc911\uc99d \uc2e0\uc7a5 \uc7a5\uc560, \ud56d\uc778\uc9c0\uc9c8 \uc99d\ud6c4\uad70 \ub4f1 \ud2b9\uc815 \uc0c1\ud669\uc5d0\uc11c\ub9cc \uc8fc\ub85c \uc0ac\uc6a9\ub429\ub2c8\ub2e4. \ub610\ud55c, AI \uae30\ubc18 \uc18c\ud504\ud2b8\uc6e8\uc5b4\ub294 \uc640\ud30c\ub9b0 \uc6a9\ub7c9 \uc870\uc808\uc744 \uac1c\uc778\ud654\ud558\uc5ec \uce58\ub8cc \ubc94\uc704 \uc678 \uc2dc\uac04(TTR)\uc744 20% \ub2e8\ucd95\ud558\uace0, \ud56d\uc751\uace0\uc81c \uad00\ub828 \ucd9c\ud608\ub85c \uc778\ud55c \uc751\uae09\uc2e4 \ubc29\ubb38\uc744 15% \uac10\uc18c\uc2dc\ud0a4\ub294 \ud6a8\uacfc\ub97c \ubcf4\uc600\uc2b5\ub2c8\ub2e4.<\/p>\n<p>2. \uc2dc\uc7a5 \uc131\uc7a5 \uc800\ud574 \uc694\uc778<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \uc8fc\uc694 NOACs\uc758 \ud2b9\ud5c8 \ub9cc\ub8cc \ubc0f \uc81c\ub124\ub9ad \uce68\uc2dd, \ucd9c\ud608 \uc704\ud5d8\uc5d0 \ub300\ud55c \uc6b0\ub824, \ub3fc\uc9c0 \ud5e4\ud30c\ub9b0 \uacf5\uae09\ub9dd\uc758 \ucde8\uc57d\uc131, \uadf8\ub9ac\uace0 RNAi\/\uc720\uc804\uc790 \uce68\ubb35 \uc81c\uc81c\uc5d0 \ub300\ud55c \uaddc\uc81c \ubd88\ud655\uc2e4\uc131 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4. 2024\ub144 \uc720\ub7fd \uc5ec\ub7ec \uad6d\uac00\uc5d0\uc11c \uc544\ud53d\uc0ac\ubc18\uc758 \ub3c5\uc810\uad8c\uc774 \uc0c1\uc2e4\ub418\uba74\uc11c \ube0c\ub79c\ub4dc \ub9e4\ucd9c\uc774 12\uac1c\uc6d4 \ub0b4 \uc57d 30% \uac10\uc18c\ud588\uc73c\uba70, \ub9ac\ubc14\ub85d\uc0ac\ubc18 \uc5ed\uc2dc \uc81c\ub124\ub9ad\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728 \ud655\ub300\ub85c \uc778\ud574 \uc720\uc0ac\ud55c \uc555\ub825\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4. 2026\ub144 \ubbf8\uad6d \ud2b9\ud5c8 \ub9cc\ub8cc\ub294 \uc774\ub7ec\ud55c \uac00\uaca9 \uc555\ub825\uc744 \ub354\uc6b1 \uc2ec\ud654\uc2dc\ud0ac \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>NOACs\uc758 \uc8fc\uc694 \ucd9c\ud608\ub960\uc740 \ud658\uc790-\ub144\ub2f9 2~3%\ub85c \ubcf4\uace0\ub418\uba70, 2024\ub144 FDA\ub294 \uc2e0\uc7a5 \uae30\ub2a5\uc774 \uc800\ud558\ub41c \uace0\ub839 \ud658\uc790\uc5d0 \ub300\ud55c \ub2e4\ube44\uac00\ud2b8\ub780\uc5d0 \ubc15\uc2a4\ud615 \uacbd\uace0\ub97c \ucd94\uac00\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub2e4\ub8e8\uc2dc\uc8fc\ub9d9(idarucizumab) \ubc0f \uc548\ub371\uc0ac\ub137 \uc54c\ud30c(andexanet alfa)\uc640 \uac19\uc740 \uc5ed\uc804\uc81c(reversal agent)\uc758 \uc81c\ud55c\uc801\uc778 \uc811\uadfc\uc131 \ubc0f \ub192\uc740 \ube44\uc6a9(\uc548\ub371\uc0ac\ub137 \uc54c\ud30c\ub294 1\ud68c \ud22c\uc5ec\ub2f9 5\ub9cc \ub2ec\ub7ec \uc774\uc0c1)\uc740 \ucde8\uc57d \uacc4\uce35\uc5d0\uc11c\uc758 \uc0ac\uc6a9\uc744 \uc81c\ud55c\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p>3. \uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>*   \uc57d\ubb3c \uacc4\uc5f4\ubcc4:<br \/>\n    *   \uc2e0\uaddc \uacbd\uad6c\uc6a9 \ud56d\uc751\uace0\uc81c(NOACs)\ub294 2025\ub144 \ud56d\uc751\uace0\uc81c \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 42.53%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ubcf4\uc600\uc2b5\ub2c8\ub2e4.<br \/>\n    *   Factor XIa \uc5b5\uc81c\uc81c\ub294 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 8.33%\uc758 \uac00\uc7a5 \ub192\uc740 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \ucd9c\ud608 \uc704\ud5d8\uacfc \ud6a8\ub2a5\uc744 \ubd84\ub9ac\ud558\ub824\ub294 \uc81c\uc57d\uc0ac\ub4e4\uc758 \ub178\ub825\uc5d0 \uae30\uc778\ud558\uba70, \ubc14\uc774\uc5d8\uc758 \uc544\uc21c\ub371\uc2dc\uc548(asundexian), \ube0c\ub9ac\uc2a4\ud1a8-\ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045(BMS)\uacfc \uc580\uc13c\uc758 \ubc00\ubca1\uc2dc\uc548(milvexian), \uc548\ud1a0\uc2a4 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Anthos Therapeutics)\uc758 \uc544\ubca8\ub77c\uc2dc\ub9d9(abelacimab) \ub4f1\uc774 \uac1c\ubc1c \uc911\uc785\ub2c8\ub2e4.<br \/>\n    *   \ud5e4\ud30c\ub9b0\uc740 \uae09\uc131\uae30 \uce58\ub8cc\uc758 \ud544\uc218\ud488\uc73c\ub85c \ub0a8\uc544\uc788\uc73c\uba70, \ube44\ud0c0\ubbfc K \uae38\ud56d\uc81c\ub294 \ud2c8\uc0c8 \uc2dc\uc7a5\uc5d0\uc11c \uc5ed\ud560\uc744 \ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \ud22c\uc5ec \uacbd\ub85c\ubcc4:<br \/>\n    *   \uacbd\uad6c \uc81c\uc81c\ub294 \ud658\uc790 \uc120\ud638\ub3c4\uc640 \ubcf5\uc6a9 \ud3b8\uc758\uc131\uc73c\ub85c \uc778\ud574 2025\ub144 \ub9e4\ucd9c\uc758 59.37%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \uc774\uc2dd\ud615 \ubc0f \uc7a5\uae30 \uc9c0\uc18d\ud615 \uc2dc\uc2a4\ud15c\uc740 \ub9e4\uc77c \uc57d\uc744 \ubcf5\uc6a9\ud574\uc57c \ud558\ub294 \ubd80\ub2f4\uc744 \uc904\uc774\ub294 \uae30\uc220 \uac1c\ubc1c\uc5d0 \ud798\uc785\uc5b4 9.67%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2024\ub144 FDA\ub294 \uc218\uc220 \ud6c4 \uc608\ubc29\uc744 \uc704\ud55c 7\uc77c \uc9c0\uc18d\ud615 \ud53c\ud558 Factor Xa \uc81c\uc81c\ub97c \uc2b9\uc778\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc801\uc6a9 \ubd84\uc57c\ubcc4:<br \/>\n    *   \uc2ec\ubc29\uc138\ub3d9 \ubc0f \uc2ec\uadfc\uacbd\uc0c9\uc740 2025\ub144 \ub9e4\ucd9c\uc758 36.93%\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \uc120\uc9c4 \uc2dc\uc7a5\uc5d0\uc11c\uc758 \uce68\ud22c\uc728 \ud3ec\ud654\ub85c \uc131\uc7a5\uc774 \ub454\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \uc554 \uad00\ub828 \ud608\uc804\uc99d\uc740 2031\ub144\uae4c\uc9c0 9.22%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4. 2024\ub144 \uc885\uc591\ud559 \uac00\uc774\ub4dc\ub77c\uc778\uc740 \ub300\ubd80\ubd84\uc758 \ud658\uc790\uc5d0\uac8c NOACs\ub97c 1\ucc28 \uce58\ub8cc\uc81c\ub85c \uad8c\uace0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc720\ud1b5 \ucc44\ub110\ubcc4:<br \/>\n    *   \ubcd1\uc6d0 \uc57d\uad6d\uc740 2025\ub144 \ub9e4\ucd9c\uc758 53.67%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ubcf4\uc600\uc2b5\ub2c8\ub2e4.<br \/>\n    *   \uc628\ub77c\uc778 \uc57d\uad6d\uc740 \ubbf8\uad6d, EU \ubc0f \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc77c\ubd80 \uc9c0\uc5ed\uc5d0\uc11c \ub514\uc9c0\ud138 \uc870\uc81c \uba74\ud5c8\uac00 \ud655\ub300\ub418\uba74\uc11c 10.46%\uc758 \uac00\uc7a5 \ub192\uc740 CAGR\ub85c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2024\ub144 \ub514\uc9c0\ud138 \uc57d\uad6d \uc778\uc99d \ud45c\uc900\uc5d0 \ud56d\uc751\uace0\uc81c \uc0c1\ub2f4\uc774 \ud3ec\ud568\ub418\uba74\uc11c \ubcf4\ud5d8\uc0ac\uc758 \uc218\uc6a9\ub3c4 \ub192\uc544\uc84c\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4. \uc9c0\uc5ed\ubcc4 \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8\ub294 2025\ub144 \ud56d\uc751\uace0\uc81c \uc2dc\uc7a5 \uaddc\ubaa8\uc758 32.65%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc785\ub2c8\ub2e4. \uba54\ub514\ucf00\uc5b4 \ud30c\ud2b8 D(Medicare Part D) \ubc0f \ubbfc\uac04 \uac00\uce58 \uae30\ubc18 \uacc4\uc57d\uc744 \ud1b5\ud55c NOACs\uc758 \uad11\ubc94\uc704\ud55c \ubcf4\uc7a5\uc774 \uc131\uc7a5\uc744 \uacac\uc778\ud588\uc2b5\ub2c8\ub2e4. \uce90\ub098\ub2e4\uc758 2024\ub144 \uc758\uc57d\ud488 \ubaa9\ub85d \ud655\ub300\uc640 \uba55\uc2dc\ucf54\uc758 \uc81c\ub124\ub9ad \uc81c\uc870\uc5c5\uccb4\uc640\uc758 \ub300\ub7c9 \uacc4\uc57d\uc774 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uae30\uc5ec\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd\uc740 \ub3c5\uc77c, \uc601\uad6d, \ud504\ub791\uc2a4, \uc774\ud0c8\ub9ac\uc544, \uc2a4\ud398\uc778\uc774 \uc9c0\uc5ed \ub9e4\ucd9c\uc758 60% \uc774\uc0c1\uc744 \ucc28\uc9c0\ud569\ub2c8\ub2e4. 2024\ub144 EU\uc758 \uc81c\ub124\ub9ad \uc544\ud53d\uc0ac\ubc18 \ubc0f \ub9ac\ubc14\ub85d\uc0ac\ubc18 \uc2b9\uc778\uc740 \uac00\uaca9\uc744 40-50% \uc778\ud558\ud558\ub294 \uacb0\uacfc\ub97c \uac00\uc838\uc654\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\uc740 8.37%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c0\uc5ed\uc785\ub2c8\ub2e4. \uc911\uad6d\uc740 2025\ub144 \uc5d0\ub3c5\uc0ac\ubc18\uc744 \uad6d\uac00 \ubcf4\ud5d8 \ubaa9\ub85d\uc5d0 \ucd94\uac00\ud558\uc5ec \ud658\uc790 \ubcf8\uc778 \ubd80\ub2f4\uae08\uc744 70% \uc808\uac10\ud588\uc2b5\ub2c8\ub2e4. \uc77c\ubcf8\uc740 \uccb4\uc911 \ud504\ub85c\ud30c\uc77c\uc5d0 \ub9de\ucd98 \uc800\uc6a9\ub7c9 \uc544\ud53d\uc0ac\ubc18 \uc81c\uc81c\uc5d0 \uc6b0\uc120 \uc2ec\uc0ac\ub97c \ubd80\uc5ec\ud588\uc73c\uba70, \uc778\ub3c4\uc758 \uc81c\ub124\ub9ad \ucd9c\uc2dc\ub85c 2, 3\uc120 \ub3c4\uc2dc\uc758 \uc218\uc694\uac00 \uc99d\uac00\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8\ub294 \uc544\uc9c1 \ucd08\uae30 \ub2e8\uacc4\uc774\uba70, \uacbd\uc81c\uc131 \ubc0f \uaddc\uc81c \ubd84\uc5f4\ub85c \uc778\ud574 \uc131\uc7a5\uc774 \uc81c\ud55c\uc801\uc785\ub2c8\ub2e4.<\/p>\n<p>5. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>2025\ub144 \uc804 \uc138\uacc4 \ub9e4\ucd9c \uae30\uc900 \uc0c1\uc704 5\uac1c \uae30\uc5c5\uc740 \ud654\uc774\uc790-\ube0c\ub9ac\uc2a4\ud1a8-\ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045(Pfizer-Bristol-Myers Squibb), \ubc14\uc774\uc5d8(Bayer), \ubca0\ub9c1\uac70\uc778\uac94\ud558\uc784(Boehringer Ingelheim), \ub2e4\uc774\uc774\ucc0c\uc0b0\ucfc4(Daiichi Sankyo), \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8(Johnson &#038; Johnson)\uc73c\ub85c, \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc785\ub2c8\ub2e4. \ud2b9\ud5c8 \ub9cc\ub8cc \uc774\ud6c4 \uc81c\ub124\ub9ad\uc758 \uce68\ud22c\ub85c \uc2dc\uc7a5 \uc810\uc720\uc728\uc774 \ubd84\uc0b0\ub418\uba74\uc11c \uae30\uc874 \uae30\uc5c5\ub4e4\uc740 \ubcf5\uc57d \uc21c\uc751\ub3c4 \uc571, \uc57d\ubb3c \uc720\uc804\uccb4 \uc11c\ube44\uc2a4\uc640 \uac19\uc740 \uc0dd\ud0dc\uacc4 \uc804\ub7b5\uc73c\ub85c \uc804\ud658\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubc14\uc774\uc5d8\uc758 2024\ub144 \ub9ac\ubc14\ub85d\uc0ac\ubc18-Factor XIa \ubcf5\ud569\uc81c \ud2b9\ud5c8 \ucd9c\uc6d0\uc740 \ubcf5\ud569\uc81c \ud601\uc2e0\uc744 \ud1b5\ud55c \uc81c\ud488 \uc218\uba85 \uc5f0\uc7a5 \ub178\ub825\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<\/p>\n<p>\uc774\uc624\ub2c8\uc2a4 \ud30c\ub9c8\uc288\ud2f0\uceec\uc2a4(Ionis Pharmaceuticals)\uc758 \ud398\uc18c\uba38\uc13c(fesomersen)\uacfc \uac19\uc740 \uc548\ud2f0\uc13c\uc2a4 \ubc0f \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4 \uac1c\ubc1c\uc0ac\ub4e4\uc740 \uc6d4 1\ud68c \ub610\ub294 \ubd84\uae30\ubcc4 \ud22c\uc5ec\ub97c \uac00\ub2a5\ud558\uac8c \ud558\ub294 \ucc28\uc138\ub300 \uce58\ub8cc\uc81c\ub97c \uac1c\ubc1c\ud558\uba70 \uc0c8\ub85c\uc6b4 \uacbd\uc7c1\uc790\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. AI \uae30\ubc18 \ub9de\ucda4\ud615 \uc6a9\ub7c9 \uc870\uc808 \ubc0f \ucd9c\ud608 \uc704\ud5d8 \uc608\uce21 \ub3c4\uad6c\ub294 \ubcf4\ud5d8\uc0ac\ub4e4\uc774 \uc2e4\uc81c \uc784\uc0c1 \uacb0\uacfc\ub97c \uba74\ubc00\ud788 \uac80\ud1a0\ud568\uc5d0 \ub530\ub77c \uc911\uc694\ud55c \ucc28\ubcc4\ud654 \uc694\uc18c\uac00 \ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud56d\uc751\uace0\uc81c \uc0b0\uc5c5\uc740 \ud2b9\ud5c8 \ubcf4\ud638 \ube14\ub85d\ubc84\uc2a4\ud130\uac00 \uc9c0\ubc30\ud558\ub294 \uacfc\uc810 \uc2dc\uc7a5\uc5d0\uc11c \uc81c\ub124\ub9ad, \ube0c\ub79c\ub4dc NOACs, \ucc28\uc138\ub300 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uac00 \uacf5\uc874\ud558\ub294 \ub2e4\uce35\uc801 \uc0dd\ud0dc\uacc4\ub85c \uc804\ud658\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>6. \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2025\ub144 11\uc6d4: \ub9ac\uc81c\ub124\ub860(Regeneron)\uc740 \ubb34\ub98e \uad00\uc808 \uce58\ud658\uc220 \ud658\uc790\uc5d0\uc11c \uc784\uc0c1\uc801\uc73c\ub85c \uc720\uc758\ubbf8\ud55c \ucd9c\ud608 \uc5c6\uc774 \ud608\uc804\uc744 \uc608\ubc29\ud558\ub294 \ub450 \uac00\uc9c0 \uc0c8\ub85c\uc6b4 Factor XI \ud56d\uccb4\uc5d0 \ub300\ud55c \uae0d\uc815\uc801\uc778 2\uc0c1 \ub370\uc774\ud130\ub97c \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 10\uc6d4: \ub8e8\ud540(Lupin)\uc740 \ubbf8\uad6d\uc5d0\uc11c \uc18c\uc544 VTE \ubc0f \ud3f0\ud0c4 \uc218\uc220(Fontan-procedure) \uc608\ubc29\uc744 \uc704\ud55c \uc0dd\ubb3c\ud559\uc801 \ub3d9\ub4f1\uc131 \ub9ac\ubc14\ub85d\uc0ac\ubc18 \uacbd\uad6c \ud604\ud0c1\uc561\uc744 \ucd9c\uc2dc\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 7\uc6d4: \ubc14\ub984\uc5d1\uc2a4(VarmX)\ub294 \uae34\uae09 \uc218\uc220 \uc911 Factor Xa DOAC \ud6a8\uacfc\ub97c \uc5ed\uc804\uc2dc\ud0a4\ub3c4\ub85d \uc124\uacc4\ub41c \ubcc0\ud615 Factor X \ub2e8\ubc31\uc9c8\uc778 VMX-C001\uc758 3\uc0c1 \uc784\uc0c1 \uc2dc\ud5d8\uc744 \uc2dc\uc791\ud558\uae30 \uc704\ud55c FDA \uc2b9\uc778\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 7\uc6d4: \ube0c\ub9ac\uc2a4\ud1a8 \ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045-\ud654\uc774\uc790 \uc5bc\ub77c\uc774\uc5b8\uc2a4(Bristol Myers Squibb-Pfizer Alliance)\ub294 Eliquis 360 \ud50c\ub7ab\ud3fc\uc744 \ud1b5\ud574 \uc5d8\ub9ac\ud034\uc2a4(Eliquis)\uc758 \ud658\uc790 \uc9c1\uc811 \uad6c\ub9e4 \uc635\uc158\uc744 \ub3c4\uc785\ud558\uc5ec \ubb34\ubcf4\ud5d8 \uc0ac\uc6a9\uc790\uc758 \ubcf8\uc778 \ubd80\ub2f4\uae08\uc744 \ub0ae\ucdc4\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc774\ucc98\ub7fc \ud56d\uc751\uace0\uc81c \uc2dc\uc7a5\uc740 \uc9c0\uc18d\uc801\uc778 \ud601\uc2e0\uacfc \uacbd\uc7c1 \uc2ec\ud654 \uc18d\uc5d0\uc11c \uc131\uc7a5\ud558\uace0 \uc788\uc73c\uba70, \ud2b9\ud788 \ucc28\uc138\ub300 \uce58\ub8cc\uc81c \uac1c\ubc1c\uacfc \ub514\uc9c0\ud138 \ud5ec\uc2a4\ucf00\uc5b4 \uc194\ub8e8\uc158\uc758 \ud1b5\ud569\uc774 \ubbf8\ub798 \uc2dc\uc7a5\uc758 \uc8fc\uc694 \ub3d9\ub825\uc774 \ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \ud608\uad00 \ub0b4 \ud608\uc804 \uce58\ub8cc \ubc0f \uc608\ubc29\uc5d0 \uc0ac\uc6a9\ub418\ub294 \ud56d\uc751\uace0\uc81c \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc2dc\uc7a5\uc740 \uc57d\ubb3c \uc885\ub958, \ud22c\uc5ec \uacbd\ub85c, \uc801\uc6a9 \ubd84\uc57c, \uc720\ud1b5 \ucc44\ub110 \ubc0f \uc9c0\uc5ed\ubcc4\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc57d\ubb3c \uc885\ub958\ubcc4\ub85c\ub294 \uc2e0\uaddc \uacbd\uad6c\uc6a9 \ud56d\uc751\uace0\uc81c(NOACs), \ud5e4\ud30c\ub9b0 \ubc0f \uc800\ubd84\uc790\ub7c9 \ud5e4\ud30c\ub9b0(LMWH), \ube44\ud0c0\ubbfc K \uae38\ud56d\uc81c, Factor XIa \uc5b5\uc81c\uc81c, \ube44\uacbd\uad6c \uc9c1\uc811 \ud2b8\ub86c\ube48 \uc5b5\uc81c\uc81c\uac00 \ud3ec\ud568\ub429\ub2c8\ub2e4. \ud22c\uc5ec \uacbd\ub85c\ubcc4\ub85c\ub294 \uacbd\uad6c\uc6a9, \uc8fc\uc0ac\uc81c, \uc774\uc2dd\ud615\/\uc7a5\uae30 \uc9c0\uc18d\ud615 \uc804\ub2ec \uc2dc\uc2a4\ud15c\uc73c\ub85c \uad6c\ubd84\ub429\ub2c8\ub2e4. \uc801\uc6a9 \ubd84\uc57c\ub294 \uc2ec\ubc29\uc138\ub3d9 \ubc0f \uc2ec\uadfc\uacbd\uc0c9, \uc2ec\ubd80\uc815\ub9e5 \ud608\uc804\uc99d, \ud3d0\uc0c9\uc804\uc99d, \uc554 \uad00\ub828 \ud608\uc804\uc99d, \uae30\uacc4\uc2dd \uc2ec\uc7a5 \ud310\ub9c9 \ubc0f \uae30\ud0c0 \uc2ec\uc7a5 \uad00\ub828 \uc6a9\ub3c4\ub97c \ub2e4\ub8f9\ub2c8\ub2e4. \uc720\ud1b5 \ucc44\ub110\uc740 \ubcd1\uc6d0 \uc57d\uad6d, \uc18c\ub9e4 \uc57d\uad6d, \uc628\ub77c\uc778 \uc57d\uad6d, \uc804\ubb38 \ud074\ub9ac\ub2c9\uc73c\ub85c \uad6c\uc131\ub429\ub2c8\ub2e4. \uc9c0\uc5ed\ubcc4\ub85c\ub294 \ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8\ub85c \uad11\ubc94\uc704\ud558\uac8c \ubd84\uc11d\ub418\uba70, \uc804 \uc138\uacc4 \uc8fc\uc694 17\uac1c\uad6d\uc758 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \ub3d9\ud5a5\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ub3d9\uc778\uc73c\ub85c\ub294 \uc2ec\ud608\uad00 \uc9c8\ud658 \ubc0f \uc2ec\ubc29\uc138\ub3d9\uc758 \uc720\ubcd1\ub960 \uc99d\uac00, \uc640\ud30c\ub9b0 \ub300\ube44 NOACs\uc758 \ube60\ub978 \ucc44\ud0dd, \uc804 \uc138\uacc4 \uace0\ub839 \uc778\uad6c \uc99d\uac00, \uc815\ub9e5\ud608\uc804\uc0c9\uc804\uc99d(VTE) \uc608\ubc29\uc744 \uc704\ud55c \uc720\ub9ac\ud55c \uc784\uc0c1 \uc9c0\uce68, AI \uae30\ubc18 \ub9de\ucda4\ud615 \ud56d\uc751\uace0\uc81c \uc6a9\ub7c9 \uc870\uc808 \ub3c4\uad6c\uc758 \ub4f1\uc7a5, \ucf54\ub85c\ub09819 \uc774\ud6c4 \uc5f0\uc7a5\ub41c \uc678\ub798 \ud608\uc804 \uc608\ubc29 \uc694\ubc95 \ub4f1\uc774 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc81c\uc57d\uc73c\ub85c\ub294 \uc544\ud53d\uc0ac\ubc18(apixaban) \ubc0f \ub9ac\ubc14\ub85d\uc0ac\ubc18(rivaroxaban) \ub4f1 \uc8fc\uc694 NOACs\uc758 \ud2b9\ud5c8 \ub9cc\ub8cc \ubc0f \uc81c\ub124\ub9ad \uce68\uc2dd\uc73c\ub85c \uc778\ud55c \ub9c8\uc9c4 \uc555\ubc15, \ucd9c\ud608 \uc704\ud5d8\uc5d0 \ub300\ud55c \uc6b0\ub824\ub85c \uc778\ud55c \ucc44\ud0dd \uc81c\ud55c, \ub3fc\uc9c0 \ud5e4\ud30c\ub9b0 \uacf5\uae09\ub9dd\uc758 \ucde8\uc57d\uc131, RNAi\/\uc720\uc804\uc790 \uce68\ubb35 \uc81c\uc81c\uc5d0 \ub300\ud55c \uaddc\uc81c \ubd88\ud655\uc2e4\uc131 \ub4f1\uc774 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p>\ud56d\uc751\uace0\uc81c \uc2dc\uc7a5\uc740 2026\ub144 375\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc774\uba70, 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 6.36%\ub85c \uc131\uc7a5\ud558\uc5ec 511\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc57d\ubb3c \uc885\ub958 \uc911\uc5d0\uc11c\ub294 Factor XIa \uc5b5\uc81c\uc81c\uac00 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 8.33%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc720\ud1b5 \ucc44\ub110 \uc911 \uc628\ub77c\uc778 \uc57d\uad6d\uc740 \ub514\uc9c0\ud138 \uc870\uc81c \uba74\ud5c8 \ud655\ub300\uc640 \ub0ae\uc740 \ubcf8\uc778 \ubd80\ub2f4\uae08\uc73c\ub85c \uc778\ud574 \ub9cc\uc131 \uc9c8\ud658 \ud658\uc790\ub4e4\uc774 \uc628\ub77c\uc778 \ud50c\ub7ab\ud3fc\uc73c\ub85c \uc804\ud658\ud558\uba74\uc11c 10.46%\uc758 CAGR\ub85c \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uc911\uad6d, \uc77c\ubcf8, \uc778\ub3c4\uc5d0\uc11c\uc758 \ubcf4\ud5d8 \uc801\uc6a9 \ud655\ub300\uc5d0 \ud798\uc785\uc5b4 8.37%\uc758 CAGR\ub85c \uac00\uc7a5 \ud070 \uc131\uc7a5\uc744 \uae30\uc5ec\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d, \uadf8\ub9ac\uace0 Alexion Pharmaceuticals, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Daiichi Sankyo Co. Ltd., Pfizer Inc., Sanofi SA \ub4f1 \uc8fc\uc694 \uae30\uc5c5 19\uacf3\uc758 \uc0c1\uc138 \ud504\ub85c\ud544\uc744 \ud3ec\ud568\ud55c \uacbd\uc7c1 \ud658\uacbd\uc744 \ub2e4\ub8f9\ub2c8\ub2e4. \uac01 \uae30\uc5c5 \ud504\ub85c\ud544\uc5d0\ub294 \uae00\ub85c\ubc8c \ubc0f \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4, \uc804\ub7b5\uc801 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d \ub4f1\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4. \ub610\ud55c, \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd, \ubbf8\ucda9\uc871 \uc218\uc694 \ud3c9\uac00\ub97c \ud1b5\ud574 \ud5a5\ud6c4 \uc2dc\uc7a5\uc758 \uc7a0\uc7ac\ub825\uc744 \ubd84\uc11d\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-34223","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/34223"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=34223"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/34223\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=34223"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=34223"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=34223"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}